# 바이오스페이스 일일 뉴스 리포트 - 2026년 01월 28일


## 주요 헤드라인

1. **Roche’s 22% Weight Loss Benefit Seals GLP-1’s Phase III Plans, Boosts Zealand Combo (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/roches-22-weight-loss-benefit-seals-glp-1s-phase-iii-plans-boosts-zealand-combo>

2. **Roche’s 22% Weight Loss Benefit Seals GLP-1’s Phase III Plans, Boosts Zealand Combo (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/roches-22-weight-loss-benefit-seals-glp-1s-phase-iii-plans-boosts-zealand-combo>

3. **Baseline Debuts To Challenge GLP-1 Giant Lilly in Alcohol Use Disorder (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/baseline-debuts-to-challenge-glp-1-giant-lilly-in-alcohol-use-disorder>

4. **CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/cytodyns-former-ceo-gets-jail-time-5-3m-fine-for-securities-fraud>

5. **JPM26 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/jpm26-biopharma-projected-positivity-in-san-francisco-now-its-time-to-execute>

6. **Big Pharma Tight-Lipped on Details of API Stockpile Deals (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/big-pharma-tight-lipped-on-details-of-api-stockpile-deals>

7. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-to-accelerate-rare-disease-progress-take-a-sandbox-approach>


---
*2026년 01월 28일 바이오스페이스 뉴스 피드에서 생성된 리포트*